Publications by authors named "Ziye Zhou"

Background: Lenalidomide is a thalidomide analog that has immunomodulatory and anti-angiogenic properties. The ECOC-ACRIN E1412 Phase II trial demonstrated that lenalidomide, when combined with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), extended survival in diffuse large B-cell lymphoma (DLBCL) patients. This study aimed to evaluate the cost-effectiveness of combining lenalidomide with R-CHOP (R2-CHOP) versus R-CHOP alone as the initial treatment for DLBCL from the perspective of the Chinese healthcare system.

View Article and Find Full Text PDF

Biological system utilizes unidirectional ion flow to produce and transmit signals. To realize bioinspired artificial intelligence and thus seamless human-machine interaction, ion rectification devices should be developed. Here, a reconfigurable CMOS-compatible supercapacitor-diode (CAPode) is developed by resettling the pseudo-capacitive and electrochemical-double-layer-capacitive components of a lithium-ion pseudocapacitor into the positive and negative voltage regions respectively through engineering the redox peaks.

View Article and Find Full Text PDF

Liver fibrosis (LF) is a common sequela to diverse chronic liver injuries, leading to rising rates of cirrhosis and hepatocellular carcinoma (HCC). As the medicinal and edible homologous material, traditional teas have exhibited promising applications in the clinical management of liver fibrosis. Here, we generated a liver fibrosis mouse model to explore the potent therapeutic ability of Ampelopsis grossedentata (AG) tea on this condition by multi-omics analysis.

View Article and Find Full Text PDF

Ethnopharmacological Relevance: Euphorbia helioscopia L. (ZQ) is a very effective traditional Chinese medicine for treating pneumonia and lung cancer. However, the effects and mechanisms by which ZQ prevents lung tumorigenesis in the presence of chronic inflammation remain unexplored.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to examine how triazole antifungal drugs influence the pharmacokinetics of lorlatinib in rats.
  • Using ultra-performance liquid chromatography (UPLC), the research analyzed the interaction of lorlatinib with specific antifungals, including ketoconazole and voriconazole, while observing blood samples collected from the rats.
  • Results indicated that ketoconazole and voriconazole significantly increased lorlatinib levels in the bloodstream, suggesting that combining these drugs should be avoided due to potential metabolism inhibition, whereas itraconazole and posaconazole had no noticeable effect.
View Article and Find Full Text PDF

Circular motion phenomena, akin to fish milling, are prevalent within the animal kingdom. This paper delineates two fundamental mechanisms underlying such occurrences: forward following and circular topological communication. Leveraging these pivotal concepts, we present a multi-agent formation circular model based on a second-order integrator.

View Article and Find Full Text PDF

Objective: This article examined the cost-effectiveness of zanubrutinib and ibrutinib for managing relapsed and refractory chronic lymphocytic leukemia from the viewpoint of payers in China and the US.

Methods: Markov models were employed to conduct comparisons. Baseline characteristics and clinical data were extracted from the ALPINE study.

View Article and Find Full Text PDF

Recently, the frequent emergence of multidrug-resistant gram-negative bacterial infections has forced colistin to be used as one of the last-line options for the treatment of these infections. This study aimed to establish and validate a simple, rapid, and reliable method for the quantitative determination of colistin in plasma and kidney homogenates by ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). The pharmacokinetic parameters of colistin sulfate in rats and the relationship between renal accumulation and time of administration in rats were estimated by measuring plasma and renal colistin concentrations.

View Article and Find Full Text PDF

Introduction: is the most prevalent biofilm-forming pathogen in dental caries, while is often detected in the presence of .

Methods: We aimed to evaluate the anti-caries effect of stevioside in medium trypticase soy broth (TSB) with or without sucrose supplementation compared with the same sweetness sucrose and xylitol in a dual-species model of and , based on planktonic growth, crystal violet assay, acid production, biofilm structural imaging, confocal laser scanning microscopy, and RNA sequencing.

Results: Our results showed that compared with sucrose, stevioside significantly inhibited planktonic growth and acid production, changed the structure of the mixed biofilm, and reduced the viability of biofilm and the production of extracellular polysaccharides in dual-species biofilm.

View Article and Find Full Text PDF

Fish interacting with biomimetic robotic fish is beneficial for animal behavior research, particularly in the study of collective behavior. Compared with passive-dragging robotic fish, self-propelled robotic fish floats in water, and its movement matches the flow field formed by the caudal fin oscillation, leading to more realistic interaction with animals. In this paper, we propose a self-propelled koi-mimicking robotic fish entity, develop a system for robotic fish and koi fish interaction, and conduct extensive experiments on quantity variation and parameter variation.

View Article and Find Full Text PDF

Group models based on simple rules are viewed as a bridge to clarifying animal group movements. The more similar a model to real-world observations, the closer it is to the essence of such movements. Inspired by the fish school, this study suggests a principle called fellow-following for group movements.

View Article and Find Full Text PDF

This study aims to assess the risk factors for insufficient vancomycin concentrations for its prophylactic use in adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) and to modify the dosing regimen to achieve appropriate plasma concentrations. A total of 27 patients with vancomycin dosing of 1 to 1.5 g based on a weight cutoff of 67 kg were included, of which only 13 (48.

View Article and Find Full Text PDF
Article Synopsis
  • Cigarette smoke is a major risk factor for chronic obstructive pulmonary disease (COPD) and lung cancer, and Anemoside B4 (B4) from the Pulsatilla chinensis herb is known for its anti-inflammatory and anti-cancer properties, but its effects on COPD had not been previously studied.
  • The research aimed to examine whether B4 could reduce inflammation and basal cell hyperplasia caused by cigarette smoke in a mouse model of COPD, alongside investigating its possible mechanisms of action.
  • The study found that B4 improved lung function, alleviated inflammation, reduced oxidative stress markers, and positively influenced several signaling pathways associated with inflammation, suggesting its potential as a therapeutic option for COPD.
View Article and Find Full Text PDF

Dual mTORC1/2 inhibitors may be more effective than mTORC1 inhibitor rapamycin. Nevertheless, their metabolic effects on breast cancer cells have not been reported. We compared the anti-proliferative capacity of rapamycin and a novel mTORC1/2 dual inhibitor (AZD8055) in two breast cancer cell lines (MDA-MB-231 and MDA-MB-453) and analyzed their metabolic effects using proton nuclear magnetic resonance (H NMR) spectroscopy-based metabolomics.

View Article and Find Full Text PDF

Crizotinib (CRIZO) has been widely employed to treat non-small-cell lung cancer. However, hepatic inflammatory injury is the major toxicity of CRIZO, which limits its clinical application, and the underlying mechanism of CRIZO-induced hepatotoxicity has not been fully explored. Herein, we used cell counting kit-8 assay and flow cytometry to detect CRIZO-induced cytotoxicity on human hepatocytes (HL-7702).

View Article and Find Full Text PDF
Article Synopsis
  • Colistin is available in two forms: colistin sulfate and colistimethate sodium (CMS), but most studies focus on CMS while data on colistin sulfate's effectiveness and side effects are limited.
  • A study involving 42 patients with carbapenem-resistant infections showed that 60% had clinical treatment success and 69% achieved bacteria elimination, with no cases of nephrotoxicity linked to colistin sulfate.
  • Pharmacokinetic modeling identified creatinine clearance as a key factor in colistin sulfate clearance, and simulations suggest optimal dosing should consider renal function to avoid underdosing.
View Article and Find Full Text PDF

Linezolid is associated with myelosuppression, which may cause failure in optimally treating bacterial infections. The study aimed to define the pharmacokinetic/toxicodynamic (PK/TD) threshold for critically ill patients and to identify a dosing strategy for critically ill patients with renal insufficiency. The population pharmacokinetic (PK) model was developed using the NONMEM program.

View Article and Find Full Text PDF

Mounting evidence demonstrates that proton pump inhibitors (PPIs) are associated with a number of adverse effects. However, the literatures about hepatotoxicity-related adverse effects (HRAEs) of PPIs are mostly case reports and a few clinical studies. We evaluated the association between PPIs and HAREs using the reporting odd ratio (ROR) for mining the adverse event report signals in the FDA Adverse Event Reporting System (FAERS) database.

View Article and Find Full Text PDF

Evidence supports linezolid therapeutic drug monitoring as the exposure-response relationship has been identified for toxicity among patients receiving linezolid, but the data to establish the upper limit are limited and the published toxicity thresholds range widely. The purpose of this study was to determine the linezolid exposure-toxicity thresholds to improve the safety of linezolid. This is a multicenter retrospective study of adult patients treated with linezolid from 2018 to 2019.

View Article and Find Full Text PDF

Aims: Data regarding clinical pharmacokinetic/toxicodynamic (PK/TD) of polymyxin B is short of direct quantitative data. This study aims to investigate the risk factors of polymyxin B associated acute kidney injury (AKI) and to assess the relationship between polymyxin B plasma levels and its nephrotoxicity.

Methods: A retrospective study was performed in adult patients treated with polymyxin B.

View Article and Find Full Text PDF

Background And Aim: Dasatinib is approved for the treatment of leukaemia worldwide. Triazole agents such as posaconazole may be used for the control of secondary fungal infection with leukaemia. This work aimed to develop a bioanalytical method to study the potential interaction between dasatinib and posaconazole.

View Article and Find Full Text PDF

Background: Joint replacement surgery provides articular cartilage samples for chondrocyte isolation. To our knowledge, the effect of the collagenase type on releasing of chondrocytes from the extracellular matrix of cartilage is not reported.

Objectives: To determine whether cartilage digested with collagenase IA yielded more chondrocytes than that digested with collagenase II and determine whether chondrocytes isolated with collagenase IA could be cultured in vitro.

View Article and Find Full Text PDF

What Is Known And Objective: Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors (ALK TKIs) are standard first-line therapy for non-small cell lung cancer patients with ALK rearrangement. Although some cases of hepatotoxicity related to these drugs have been reported, there is still a lack of investigation on severe hepatotoxicity, such as hepatic failure, with ALK TKIs.

Methods: We evaluated ALK TKI (crizotinib, alectinib, brigatinib, ceritinib and lorlatinib)-induced hepatic failure events (AIHFEs), by using the Reporting Odds Ratio (ROR) and Bayesian Confidence Propagation Neural Network method for mining the adverse event report signals in the FDA Adverse Event Reporting System (FAERS) database from Jan 2013 to Dec 2019.

View Article and Find Full Text PDF

Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic or advanced non-small cell lung cancer (NSCLC) whose tumors have specific EGFR mutations. Pulmonary toxicity is one of the fatal adverse effects of gefitinib and the underlying mechanism remains unclear. Here we demonstrated that alveolar macrophages contributed to gefitinib-induced pulmonary toxicity through promoting alveolar epithelial cells to undergo epithelial to mesenchymal transition (EMT) and inducing activation and antiapoptotic effect in fibroblasts.

View Article and Find Full Text PDF